These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6573326)

  • 1. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
    Hart CA; Percival A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():95-101. PubMed ID: 6573329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro bactericidal effect of cefotetan-aminoside combinations].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):361-5. PubMed ID: 3043329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
    Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
    Just HM; Becker C; Bassler M; Daschner FD
    Chemotherapy; 1984; 30(6):387-91. PubMed ID: 6596165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
    Dette GA; Knothe H; Henckel S
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
    Morel C; Vergnaud M; Langeard MM; Dupuy L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotetan activity against Gram-negative aerobes and anaerobes.
    Moosdeen F; Maskell J; Philpott-Howard J; Williams JD
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():59-65. PubMed ID: 6601657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
    Leigh DA; Marriner J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
    Shah PM; Belve V
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
    Grimm H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activity of cefotetan against Serratia spp. and Enterobacter spp. in comparison with other cephalosporins.
    Campello C; Stradoni R; Majori L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():87-93. PubMed ID: 6573328
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.